{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:26:06Z","timestamp":1762431966952,"version":"3.41.2"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T00:00:00Z","timestamp":1612224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870998","81801254","81901283"],"award-info":[{"award-number":["81870998","81801254","81901283"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p>Social media listening (SML) is a new process for obtaining information from social media platforms to generate insights into users' experiences and has been used to analyze discussions about a multitude of diseases. To understand Parkinson's disease patients' unmet needs and optimize communication between doctors and patients, social media listening was performed to investigate concerns in Chinese patients. A comprehensive search of publicly available social media platforms with Chinese-language content posted between January 2005 and April 2019 in mainland China was performed using defined Parkinson's disease-related terms. After multiple steps of machine screening were performed, a series of posts were derived. The content was summarized and classified manually to analyze and map psychological insights, and descriptive statistics were applied to aggregate findings. A total of 101,899 patient-related posts formed the basis of this study. The topics mainly focused on motor symptoms (<jats:italic>n<\/jats:italic> = 54,983), choice of pharmaceutical drugs (<jats:italic>n<\/jats:italic> = 45,203) and non-motor symptoms (<jats:italic>n<\/jats:italic> = 44,855). The most common symptoms mentioned were tremor (54.5%), pain (22.9%), and rigidity (22.1%). Psychological burden (51%) and work\/social burden (48%) were the most concerning burdens for patients and their families. The compound levodopa (43%) and dopamine agonists (23%) were the most common options for the patients, while concerns about new-generation anti-Parkinson's disease medication increased. The portraits of patients suggested varying characteristics across different periods and advocate for personalized service from doctors. In the management of patients, it is imperative to plan individualized therapy and education strategies as well as strategies for social support.<\/jats:p>","DOI":"10.3389\/fpsyt.2021.615743","type":"journal-article","created":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T05:59:22Z","timestamp":1612245562000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Findings in Chinese Patients With Parkinson's Disease: A Content Analysis From the SML Study"],"prefix":"10.3389","volume":"12","author":[{"given":"Yiwei","family":"Qian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqin","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaoqing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengjun","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomeng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengjuan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1159\/000445751","article-title":"The incidence of Parkinson's disease: a systematic review and meta-analysis","volume":"46","author":"Hirsch","year":"2016","journal-title":"Neuroepidemiology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40035-019-0162-z","article-title":"Parkinson's disease in China: a forty-year growing track of bedside work","volume":"8","author":"Li","year":"2019","journal-title":"Transl Neurodegener"},{"key":"B3","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","article-title":"Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030","volume":"68","author":"Dorsey","year":"2007","journal-title":"Neurology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"B5","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.parkreldis.2014.12.031","article-title":"The burden of non-motor symptoms in Parkinson's disease using a self-completed non-motor questionnaire: a simple grading system","volume":"21","author":"Chaudhuri","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"key":"B6","doi-asserted-by":"publisher","first-page":"00128","DOI":"10.1183\/23120541.00128-2018","article-title":"Patients' perspectives on COPD: findings from a social media listening study","volume":"5","author":"Cook","year":"2019","journal-title":"ERJ Open Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e002819","DOI":"10.1136\/bmjopen-2013-002819","article-title":"Social media use among patients and caregivers: a scoping review","volume":"3","author":"Hamm","year":"2013","journal-title":"BMJ Open"},{"key":"B8","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s40123-019-0188-4","article-title":"Evaluating patient experiences in dry eye disease through social media listening research","volume":"8","author":"Cook","year":"2019","journal-title":"Ophthalmol Ther"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.2196\/jmir.7485","article-title":"Using social media to characterize public sentiment toward medical interventions commonly used for cancer screening: an observational study","volume":"19","author":"Metwally","year":"2017","journal-title":"J Med Internet Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e62","DOI":"10.2196\/jmir.5409","article-title":"Patterns of treatment switching in multiple sclerosis therapies in US patients active on social media: application of social media content analysis to health outcomes research","volume":"18","author":"Risson","year":"2016","journal-title":"J Med Internet Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1097\/MIB.0000000000001110","article-title":"Patient understanding of the risks and benefits of biologic therapies in inflammatory bowel disease: insights from a large-scale analysis of social media platforms","volume":"23","author":"Martinez","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s13167-017-0113-7","article-title":"Qualitative analysis of Parkinson's disease information on social media: the case of YouTube\u2122","volume":"8","author":"Al-Busaidi","year":"2017","journal-title":"EPMA J"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e12126","DOI":"10.2196\/12126","article-title":"Provision of paid web-based medical consultation in China: cross-sectional analysis of data from a medical consultation website","volume":"21","author":"Li","year":"2019","journal-title":"J Medical Internet Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/mdc3.12511","article-title":"Acute levodopa challenge test in patients with de novo Parkinson's disease: data from the DeNoPa cohort","volume":"4","author":"Schade","year":"2017","journal-title":"Mov Disord Clin Pract."},{"key":"B15","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S0140-6736(05)70801-1","article-title":"Parkinson's disease in China: prevalence in Beijing, Xian, and Shanghai","volume":"365","author":"Zhang","year":"2005","journal-title":"Lancet"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1212\/CON.0000000000000345","article-title":"Diagnosing Parkinson disease","volume":"22","author":"Hess","year":"2016","journal-title":"Continuum"},{"key":"B17","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s40263-012-0012-3","article-title":"Postural instability in patients with Parkinson's disease. Epidemiology, pathophysiology and management","volume":"27","author":"Kim","year":"2013","journal-title":"CNS Drugs"},{"key":"B18","doi-asserted-by":"publisher","first-page":"469","DOI":"10.2147\/JMDH.S105857","article-title":"Pain management in patients with Parkinson's disease: challenges and solutions","volume":"9","author":"Skogar","year":"2016","journal-title":"J Multidiscip Healthc"},{"key":"B19","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.3233\/JPD-202069","article-title":"Management of pain in Parkinson's disease","volume":"10","author":"Buhmann","year":"2020","journal-title":"J Parkinsons Dis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1002\/mds.22868","article-title":"The non-declaration of non-motor symptoms of Parkinson's disease to health care professionals: an international study using the non-motor symptoms questionnaire","volume":"25","author":"Chaudhuri","year":"2010","journal-title":"Mov Disord"},{"key":"B21","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3233\/JPD-191683","article-title":"Parkinson's disease in women and men: what's the difference?","volume":"9","author":"Cerri","year":"2019","journal-title":"J Parkinsons Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1007\/s00415-011-6392-3","article-title":"Gender-related differences in the burden of non-motor symptoms in Parkinson's disease","volume":"259","author":"Martinez-Martin","year":"2012","journal-title":"J Neurol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.parkreldis.2018.06.001","article-title":"A detailed clinical study of pain in 1957 participants with early\/moderate Parkinson's disease","volume":"56","author":"Silverdale","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"key":"B24","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1136\/jnnp-2017-317378","article-title":"Functional neurological disorders in Parkinson disease","volume":"89","author":"Wissel","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1177\/0891988718757369","article-title":"Clinical markers of anxiety subtypes in Parkinson disease","volume":"31","author":"Broen","year":"2018","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1159\/000189269","article-title":"Parkinson's disease with and without REM sleep behaviour disorder: are there any clinical differences?","volume":"61","author":"Yoritaka","year":"2009","journal-title":"Eur Neurol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.sleep.2014.10.020","article-title":"Gender differences in REM sleep behavior disorder: a clinical and polysomnographic study in China","volume":"16","author":"Zhou","year":"2015","journal-title":"Sleep Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"576121","DOI":"10.3389\/fneur.2020.576121","article-title":"The impact of sex and gender on the multidisciplinary management of care for persons with Parkinson's disease","volume":"11","author":"G\u00f6ttgens","year":"2020","journal-title":"Front Neurol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.parkreldis.2012.09.004","article-title":"Systematic review on factors associated with medication non-adherence in Parkinson's disease","volume":"18","author":"Daley","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"B30","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jns.2007.08.028","article-title":"Motor complications in Parkinson disease: clinical manifestations and management","volume":"266","author":"Bhidayasiri","year":"2008","journal-title":"J Neurol Sci"},{"key":"B31","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1055\/s-0037-1602423","article-title":"Motor complications of dopaminergic medications in Parkinson's disease","volume":"37","author":"Freitas","year":"2017","journal-title":"Semin Neurol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.11477\/mf.1416200556","article-title":"Patients' perspective on Parkinson disease therapies: comparative results of large-scale surveys in 2008 and 2013 in Japan","volume":"68","author":"Fujimoto","year":"2016","journal-title":"Brain Nerve"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e99377","DOI":"10.1371\/journal.pone.0099377","article-title":"Efficacy and safety of Tai Chi for Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials","volume":"9","author":"Ni","year":"2014","journal-title":"PLoS ONE"},{"key":"B34","doi-asserted-by":"publisher","first-page":"9626934","DOI":"10.1155\/2019\/9626934","article-title":"Effects of Tai Chi exercise on reducing falls and improving balance performance in Parkinson's disease: a meta-analysis","volume":"2019","author":"Liu","year":"2019","journal-title":"Parkinsons Dis"},{"key":"B35","doi-asserted-by":"publisher","first-page":"8762939","DOI":"10.1155\/2017\/8762939","article-title":"Economic burden analysis of Parkinson's disease patients in China","volume":"2017","author":"Yang","year":"2017","journal-title":"Parkinsons Dis"},{"key":"B36","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.3233\/JPD-181519","article-title":"Management of Parkinson's disease 20 years from now: towards digital health pathways","volume":"8","author":"Klucken","year":"2018","journal-title":"J Parkinsons Dis"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2021.615743\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T05:59:25Z","timestamp":1612245565000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2021.615743\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,2]]},"references-count":36,"alternative-id":["10.3389\/fpsyt.2021.615743"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2021.615743","relation":{},"ISSN":["1664-0640"],"issn-type":[{"type":"electronic","value":"1664-0640"}],"subject":[],"published":{"date-parts":[[2021,2,2]]},"article-number":"615743"}}